康辰药业：股东刘建华持有公司股份比例由47.29%减少至46.65%

Core Points - 康辰药业's shareholder Liu Jianhua reduced his stake in the company by a total of 1.0215 million shares through centralized bidding and block trading on October 17, 2025 [1] - Following this equity change, Liu Jianhua and his concerted parties' total shareholding decreased from 75.3634 million shares to 74.3419 million shares, representing a reduction in ownership from 47.29% to 46.65%, which touches the 1% threshold for equity changes [1]